AccessibilityHelp
Haleon Plc logo

Haleon Plc(NYSE) HLN

Market Cap$45.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+46%
5 YearN/A
1 Year+12%
1 Month+13%
Premium Feature
Moneyball Superscore
54/100
$10.29
-0.82%
-0.09Today
After hours$10.28-$0.01 (-0.05%)
Haleon Plc last closing stock price
MetricPriceDate
Last closeUSD 10.272026-10-23
Haleon Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.38%USD 10.132026-10-16
1 month+12.73%USD 9.112026-09-23
3 month+5.71%USD 9.722026-07-24
Year to date+3.64%USD 9.912025-12-31
1 year+11.82%USD 9.182025-10-23
3 year+31.51%USD 7.812023-10-24
Since inception+46.48%USD 7.012022-07-18

Haleon Plc Financials at a Glance

Market Cap

$45.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£19.38B

Net Income (TTM)

£2.83B

EPS (TTM)

$0.49

P/E Ratio

21.01

Dividend

$0.20

Beta (Volatility)

0.16 (Low)

Price

$10.29

Volume

6,604.853

Open

$10.30

Previous Close

$10.27

Daily Range

$10.22 - $10.34

52-Week Range

$8.65 - $11.28

Estimated Earnings Date

Mar 4, 2027

HLN News

GettyImages-2245098525-1200x800-5b2df79

Prediction: These 3 Dividend Stocks Will Raise Their Payouts No Matter What the Market Does

Micah ZimmermanOct 14, 2026

HLN: Motley Fool Moneyball Superscore

54

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haleon Plc

Haleon plc is a prominent global player in the consumer healthcare sector, focusing on the development, production, and distribution of wellness products. Established in 2021 and headquartered in Brentford, United Kingdom, the company offers a diverse range of therapeutic solutions across various health categories.

Products and Services
  • Oral care products including Sensodyne and Polident
  • Pain management solutions such as Panadol and Voltaren
  • Vitamins and dietary supplements like Centrum
Growth Outlook
  • Revenue for Q2 2026 reached $5.64 billion, showing strong demand
  • Net income for Q2 2026 was $767.6 million, reflecting profitability
  • Operating income margin improved to 23.8% in Q2 2026, indicating operational efficiency
Financial Highlights
  • Trailing twelve months (TTM) revenue of $22.5 billion, showcasing consistent growth
  • Dividend yield of 1.92%, providing a return to shareholders
  • Net profit margin of 14.55% TTM, demonstrating effective cost management
Haleon plc operates in a competitive landscape, yet its established brands and innovative product offerings position it well for future growth. The company's focus on consumer health aligns with increasing global health awareness, making it a compelling option for investors interested in the healthcare sector. Recent financial performance indicates a robust operational framework, with significant revenue and profit margins that reflect effective management strategies. The commitment to research and development further enhances its potential for long-term success in the consumer healthcare market.
AI Generated • Oct 25, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Brian James McNamara, MBA

Website

www.haleon.com

Headquarters

Weybridge, SU KT13 0NY, GB

HLN Financials

Key Financial Metrics (TTM)

Gross Margin

65.57%

Operating Margin

21.35%

Net Income Margin

14.55%

Return on Equity

9.89%

Return on Capital

9.65%

Return on Assets

4.98%

Earnings Yield

4.76%

Dividend Yield

1.93%

Payout Ratio

39.00%

Stock Overview

Market Cap

$45.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.40B

Volume

6.60K

Avg. Volume

15.15M

Financials (TTM)

Gross Profit

£12.62B

Operating Income

£4.40B

EBITDA

£5.01B

Operating Cash Flow

£3.52B

Capital Expenditure

-£434.44M

Free Cash Flow

£3.08B

Cash & ST Invst.

£821.01M

Total Debt

£8.20B

Haleon Plc Performance Analysis

Haleon Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 13,374,669,1971.9%
20232023-12-31GBP 14,048,971,9195.0%
20242024-12-31GBP 14,353,665,6892.2%
20252025-12-31GBP 14,536,329,5781.3%
Haleon Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-50.5%
Q22025-06-30100.0%
Q42025-12-31N/A
Q22026-06-30N/A
Haleon Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.28-31.7%
20232023-12-31GBP 0.28-0.4%
20242024-12-31GBP 0.4042.6%
20252025-12-31GBP 0.4921.2%
Haleon Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-42.9%
Q22025-06-30100.0%
Q42025-12-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£5.64B

+1.9%

Gross Profit

£3.73B

+9.6%

Gross Margin

66.05%

N/A

Market Cap

$45.16BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.84M

N/A

Employees

24,535

N/A

Net Income

£767.62M

+7.2%

EBITDA

£1.52B

+13.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£821.01M

+54.6%

Total Debt

£8.20B

-7.4%

Accounts Receivable

£2.33B

+9.3%

Inventory

£1.06B

-27.2%

Long Term Debt

£6.25B

-15.6%

Short Term Debt

£1.95B

+34.4%

Return on Assets

4.98%

N/A

Return on Invested Capital

9.04%

N/A

Free Cash Flow

£791.80M

N/A

Operating Cash Flow

£902.61M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SDZNYSandoz Group AG
$97.17+0.83%
KVUEKenvue Inc.
$19.57-1.56%
CHDChurch & Dwight Co., Inc.
$105.19-3.37%
CLColgate-Palmolive Company
$94.04-3.44%

Trending Stocks

Symbol / CompanyPricePrice Chg
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$77.05-0.07%
EWZiShares - iShares Msci Brazil ETF
$42.59+1.77%
NUNu Holdings
$15.16+2.92%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%

Questions About HLN

What is the current price of Haleon Plc?

Haleon Plc is trading at $10.27 per share.

What is the 52-week range for Haleon Plc?

Over the past 52 weeks, Haleon Plc has traded between $8.65 and $11.28.

How much debt does Haleon Plc have?

As of the most recent reporting period, Haleon Plc reported total debt of £11.58B.

How much cash does Haleon Plc have on hand?

Haleon Plc reported £1.78B in cash and cash equivalents in its most recent financial results.

What is Haleon Plc’s dividend yield?

Haleon Plc currently has a dividend yield of 1.93%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services